• Skip to primary navigation
  • Skip to main content
  • 786-300-3183
  • executiveoffice@fsahq.org
  • Facebook
  • Twitter
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • Distinguished Service Award Past Recipients
      • President Engagement Award Past Recipients
      • FSA Past Presidents
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • Annual Meeting
    • Call For Abstracts
    • Meeting Info
    • Past Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
    • Calendar of Events
  • FSAPAC
    • Donate to FSAPAC
    • FSAPAC 2020 Donor Honor Roll
    • FSAPAC 2019 Donor Honor Roll
  • Current Newsletter
    • Past FSA Newsletters
  • Member Login
  • Legislative Advocacy
    • Legislative Updates
    • Doctor of the Day
  • Become a Member / Renew Your Membership
    • Become an FSA Member
    • Membership Renewal
  • Member Portal
  • Made for this Moment

2020 FSA Posters

P051: SUCCESSFUL RE-IMPLANTATION OF SPINAL CORD STIMULATOR ONE YEAR AFTER DEVICE REMOVAL DUE TO INFECTION
Ruben Schwartz, DO1; Warren Southerland, MD2; Ivan Urits, MD2; Alan Kaye, MD3; Omar Viswanath, MD4; 1Mount Sinai Medical Center of Florida; 2Beth Israel Deaconness Medical Center; 3Louisiana State University Health Science Center; 4Valley Anesthesiology and Pain Consultants

Spinal cord stimulation (SCS) is an effective treatment modality for patients with chronic pain. SCS has demonstrated clinical benefit in patients with complex regional pain syndrome, failed back surgery syndrome, critical limb ischemia, and refractory angina pectoris. SCS therapy comes with the risk of potential complications including device failure, lead migration, loss of therapeutic paresthesia, and infection. For most clinicians, the management of these complications involves removal of the device and immediate re-implantation, except in the case of an infection. Although only seen in approximately 2.45% of SCS implants, infected devices are some of the most dreaded complications and add the risk of meningitis, epidural abscess, and vertebral osteomyelitis. It is crucial for physicians to recognize potential infections in a timely manner to prevent these more serious adverse effects. After explantation and initiation of antibiotic coverage, the question remains; what is the appropriate time to wait to re-implant? We briefly describe the case of the removal of an infected SCS device and successful re-implantation after a year. 

Copyright © 2021 Florida Society of Anesthesiologists ยท Managed by BSC Management, Inc.